1
Up to 14.9% mean body weight reduction over 68 weeks versus placebo in the STEP clinical trial programme.
View on PubMed →
VIP 001 Semaglux EU
Tax included where applicable. Shipping calculated at checkout.
Semaglutide is a GLP-1 receptor agonist with extensive Phase III clinical data. The STEP trial programme demonstrated up to 14.9% mean body weight reduction over 68 weeks. One of the most studied compounds in metabolic research, with regulatory approval for multiple indications.
Every batch is independently tested by a 3rd party laboratory. Certificate of Analysis available below.
Out of stock
This product is currently unavailable. Check the recommended alternatives below, or contact us for restock updates.
The more you buy, the more you save
Buy 5
-5%
discount
Buy 7
-7.5%
discount
BEST DEAL
Buy 10+
-10%
discount
Every batch is tested by an independent third-party laboratory with no commercial relationship to Camo Chem. We never self-certify. The full Certificate of Analysis is published on this page and verifiable directly with the testing lab.
Worldwide shipping. UK orders typically delivered in 1-3 working days. EU and international orders 3-7 working days. Tracked and signed-for delivery. Free shipping over £65 (UK) / €110 (EU) / $110 (US).
Store lyophilised powder in a cool, dry place. After reconstitution, refrigerate at 2-8°C.
Don't forget
Bacteriostatic water
Required for reconstituting lyophilised peptides. European Warehouse.
Reconstitution
Need help with dosing?
Calculate the exact volume of bacteriostatic water for your target dose.
Worldwide ShippingUK · EU · USA · Asia
3rd Party TestedIndependent lab CoA
≥98% HPLC PurityVerified per batch
Safe DeliveryDiscreet packaging
Research Overview
About this compound
What does the research say?
Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist that mimics the action of the naturally occurring incretin hormone GLP-1. It activates GLP-1 receptors to stimulate insulin secretion, suppress glucagon release, delay gastric emptying, and reduce appetite through central nervous system signalling.
In the STEP clinical trial programme, semaglutide produced mean body weight reductions of up to 14.9% over 68 weeks compared to placebo. The compound received regulatory approval for both type 2 diabetes and chronic weight management, becoming one of the most commercially significant peptide compounds in pharmaceutical history. Additional trials have investigated cardiovascular outcomes, showing a 20% reduction in major adverse cardiovascular events.
These are not marketing claims. These are peer-reviewed, published results. You can verify every reference below.
Why does quality matter?
Semaglutide is a complex 31-amino acid peptide with a fatty acid chain modification (C18 acyl chain) that extends its half-life to approximately 7 days. This modification must be correctly conjugated for the compound to have its characteristic extended duration of action.
At Camo Chem, every batch is tested by an independent 3rd party laboratory. We publish the full Certificate of Analysis for every batch, and you can verify the results directly with the lab. We do not self-certify. Ever.
Ask your current supplier: who tests their products?
Technical Data
Compound specifications
| Common Names | Semaglutide |
| CAS Number | 910463-68-2 |
| Molecular Weight | 4,113.58 g/mol |
| Amino Acids | 31 (with C18 fatty acid modification) |
| Classification | GLP-1 receptor agonist |
| Purity | ≥98% (HPLC verified) |
| Content per Vial | 5 mg |
| Physical Form | Lyophilised (freeze-dried) white powder |
| Solubility | Soluble in water and bacteriostatic water |
| Storage | Powder: cool, dry place. After reconstitution: 2-8°C. |
Peer-reviewed Studies
Published research on Semaglutide
2
20% reduction in major adverse cardiovascular events in clinical trials.
View on PubMed →3
Regulatory approval for both type 2 diabetes management and chronic weight management based on extensive Phase III data.
View on PubMed →
Customer Reviews
What researchers are saying
5.0
6 reviews
5★
6
4★
0
3★
0
2★
0
1★
0
★★★★★
Quality and price top
★★★★★
Works wonders with my two rats, recommended product.
★★★★★
Ottimo prodotto! Soddisfa appieno le aspettative.
FAQ
Frequently asked questions
Semaglutide is a GLP-1 receptor agonist with CAS number 910463-68-2. It is a 31-amino acid peptide with a C18 fatty acid modification that extends its half-life to approximately 7 days. It has received regulatory approval for multiple indications. This product is sold exclusively as a research compound.
Every batch meets a minimum of 98% purity as verified by HPLC. Testing is performed by an independent 3rd party laboratory.
By an independent laboratory with no commercial relationship with our company. We do not self-certify.
Yes. Semaglutide is supplied as a lyophilised powder and must be reconstituted with bacteriostatic water before use.
In lyophilised form, store in a cool, dry place. After reconstitution, refrigerate at 2-8°C.
